IL324503A - נגזרות אוקסופיפראזין לטיפול בסרטן - Google Patents

נגזרות אוקסופיפראזין לטיפול בסרטן

Info

Publication number
IL324503A
IL324503A IL324503A IL32450325A IL324503A IL 324503 A IL324503 A IL 324503A IL 324503 A IL324503 A IL 324503A IL 32450325 A IL32450325 A IL 32450325A IL 324503 A IL324503 A IL 324503A
Authority
IL
Israel
Prior art keywords
cancer
treatment
oxopiperazine derivatives
oxopiperazine
derivatives
Prior art date
Application number
IL324503A
Other languages
English (en)
Inventor
Itys Vacher-Comet
Paul Andreas Compare Cloos
Bernd Hentsch
Jonathan Fullerton ST?IER
Original Assignee
Inthera Bioscience AG
Vacher Comet Itys
Paul Andreas Compare Cloos
Bernd Hentsch
Jonathan Fullerton ST?IER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inthera Bioscience AG, Vacher Comet Itys, Paul Andreas Compare Cloos, Bernd Hentsch, Jonathan Fullerton ST?IER filed Critical Inthera Bioscience AG
Publication of IL324503A publication Critical patent/IL324503A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL324503A 2023-05-26 2025-11-06 נגזרות אוקסופיפראזין לטיפול בסרטן IL324503A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363504576P 2023-05-26 2023-05-26
US202363513220P 2023-07-12 2023-07-12
PCT/EP2024/064461 WO2024245974A1 (en) 2023-05-26 2024-05-24 Oxopiperazine derivatives for the treatment of cancer

Publications (1)

Publication Number Publication Date
IL324503A true IL324503A (he) 2026-01-01

Family

ID=91375314

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324503A IL324503A (he) 2023-05-26 2025-11-06 נגזרות אוקסופיפראזין לטיפול בסרטן

Country Status (4)

Country Link
AU (1) AU2024281858A1 (he)
IL (1) IL324503A (he)
MX (1) MX2025014114A (he)
WO (1) WO2024245974A1 (he)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
IL275337B2 (he) 2017-12-15 2024-06-01 Inthera Bioscience AG נגזרות 1-(פיפרידינוקרבונילמתיל)-2-אוקסופיפראזין לטיפול בסרטן
WO2021144302A1 (en) * 2020-01-13 2021-07-22 Inthera Bioscience AG Biomarkers for determining susceptibility to oxopiperazine derivatives and methods of using same
WO2021255239A1 (en) * 2020-06-19 2021-12-23 Inthera Bioscience AG Oxopiperazine derivatives for the treatment of cancer
US12006300B2 (en) 2020-08-14 2024-06-11 Minerva Neurosciences, Inc. Sigma ligand compounds and uses thereof

Also Published As

Publication number Publication date
MX2025014114A (es) 2026-01-07
AU2024281858A1 (en) 2025-11-27
WO2024245974A1 (en) 2024-12-05

Similar Documents

Publication Publication Date Title
IL316706A (he) תרכובות מקרו-מחזור לטיפול בסרטן
EP3781564A4 (en) Compounds for the treatment of cancer
AU2024220916A1 (en) Tricyclic compounds for the treatment of cancer
EP4171548A4 (en) COMBINATION THERAPY FOR THE TREATMENT OF CANCER
EP4010081A4 (en) POLYTHERAPY FOR THE TREATMENT OF CANCER
ZA202206743B (en) Therapy for the treatment of cancer
IL304595A (he) נגזרות טטרהידרוזפין ביציקליות לטיפול בסרטן
IL312171A (he) שימוש חדשני בתרכובת קינאזולינון לטיפול בסרטן
IL316829A (he) מעכבי מנין-mll לטיפול בסרטן
SG11202108636SA (en) Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer
IL305780A (he) שיטות לטיפול בסרטן
IL289201A (he) תרכובות לטיפול בסרטן
IL324503A (he) נגזרות אוקסופיפראזין לטיפול בסרטן
AU2022231043A1 (en) Chaperonin-containing tcp-1 inhibitors for the treatment of cancer
EP4157246B8 (en) Therapeutic combination for the treatment of breast cancer
CA3292752A1 (en) Oxopiperazine derivatives for the treatment of cancer
AU2021372815A9 (en) Combination treatment of cancer
HK40114414A (en) Dr5-targeting multabodies for the treatment of cancer
IL315444A (he) מערכת ביטוי לטיפול בסרטן
HK40094743A (en) Combinations for the treatment of cancer
HK40119944A (en) Use of niraparib for the treatment of brain cancer
HK40097938A (en) Combination therapy for the treatment of cancer
CA3263777A1 (en) DYSOSMOBACTER FOR THE TREATMENT OF BREAST CANCER
IL320482A (he) טיפול משולב לטיפול בסרטן
CA3271803A1 (en) Combination therapy for the treatment of cancer